Results 121 to 130 of about 141,463 (194)

Diagnostic Accuracy of Combination of Multiparametric MRI PI-RADS Score v2.1 and Prostate-Specific Antigen Density for Prostate Cancer Detection. [PDF]

Cureus
Shetty A, Gadupati J, Bommineni B, Chikatla S, Krishnamurthy U, D R.   +5 more
europepmc   +1 more source

New model of PIRADS and adjusted prostatespecific antigen density of peripheral zone improves the detection rate of initial prostate biopsy: a diagnostic study. [PDF]

Asian J Androl, 2023
Huang C, Cai ZQ, Qiu F, Pu JX, Xi QL, Wei XD, Wang XM, Zhao XJ, Guo LC, Hou JQ, Huang YH.   +10 more
europepmc   +1 more source

Predictive Value of Prostate-Specific Antigen Density on Tumour Grade in Diagnosis of Prostate Cancer: A Hospital-Based Cross-Sectional Study. [PDF]

Niger Med J
Ozah E, Agbugui JO.
europepmc   +1 more source

The use of prostate specific antigen density to predict clinically significant prostate cancer. [PDF]

Sci Rep, 2020
Yusim I, Krenawi M, Mazor E, Novack V, Mabjeesh NJ.   +4 more
europepmc   +1 more source

Unified model involving genomics, magnetic resonance imaging and prostate-specific antigen density outperforms individual co-variables at predicting biopsy upgrading in patients on active surveillance for low risk prostate cancer. [PDF]

Cancer Rep (Hoboken), 2022
Beksac AT, Ratnani P, Dovey Z, Parekh S, Falagario U, Roshandel R, Sobotka S, Kewlani D, Davis A, Weil R, Bashorun H, Jambor I, Lewis S, Haines K, Tewari AK.   +14 more
europepmc   +1 more source

Prostate cancer with elevated free prostate-specific antigen density: A case report. [PDF]

World J Clin Cases
Huang DH, Hu YX, Guo S, Yang WJ.
europepmc   +1 more source

Early experience in avoiding biopsies for biopsy-naïve men with clinical suspicion of prostate cancer but non-suspicious biparametric magnetic resonance imaging results and prostate-specific antigen density < 0.15 ng/mL²: A 2-year follow-up study. [PDF]

Acta Radiol Open, 2022
Kortenbach KC, Løgager V, Thomsen HS, Boesen L.   +3 more
europepmc   +1 more source

Transition zone-based prostate-specific antigen density for differentiating clinically significant prostate cancer in PI-RADS score 3 lesions. [PDF]

Sci Rep
Jin Y, Chen F, Xu G, Wei C, Dong C.
europepmc   +1 more source

Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation. [PDF]

BJU Int, 2021
Schoots IG, Padhani AR.
europepmc   +1 more source

A unique cellular and molecular microenvironment is present in tertiary lymphoid organs of patients with spontaneous prostate cancer regression [PDF]

, 2017
de la Luz Garcia-Hernandez, Maria, Espinosa-Gonzalez, Ricardo, Kast, W. Martin, Khader, Shabaana A, Rangel-Moreno, Javier, Uribe-Uribe, Norma Ofelia   +5 more
core   +2 more sources